Protocols
5 protocol(s) meet the specified criteria
PI: Lee, Carrie
Protocol No.TitleStatus
A081105-CIRBRandomized Double Blind Placebo Controlled Study of Erlotinib or Placebo In Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC) Open
A151216-CIRBAdjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)Open
E4512-CIRBA Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion ProteinOpen
ECOG1609-CIRBA Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Vs High Dose Interferon alpha2b for Resected High-Risk Melanoma Open (affiliates only)
GO29322A Phase Ib Study of the Safety and Pharmacology of Atezolizumab (Anti-PD-L1 Antibody) Administered with Ipilimumab, Interferon-Alpha, or Other Immune-Modulating Therapies in Patients with Locally Advanced or Metastatic Solid TumorsOpen